SEC Filing Analysis: Avidity Biosciences, Inc. (RNA)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Commercial Officer acquired 72,000 shares through the vesting of performance-based stock units (PSUs) and simultaneously disposed of 47,990 shares to cover tax obligations. This is a non-discretionary event related to executive compensation.
• Market Impact: The transaction is considered routine and is unlikely to have a material impact on the stock price.

Company Information

Field	Value
Company	Avidity Biosciences, Inc.
Ticker Symbol	RNA
CIK	0001599901
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	Mosbrooker Eric
CIK	0001715283
Title/Position	Chief Commercial Officer
Relationship	Officer

Transaction Details

This filing reports multiple transactions on the same day. The primary event is an award, followed by dispositions to cover taxes.

Transaction 1: Award (Vesting)

Field	Value
Form Type	4
Transaction Date	2025-12-17
Transaction Code	A (Award)
Security Type	Common Stock
Shares Involved	72,000
Price Per Share	$0.00
Total Value	$0 (Market value of ~$5.17M based on tax sale price)
Ownership Type	Direct

Transaction 2 & 3: Tax Withholding

Field	Value
Transaction Code	F (Payment of tax liability by withholding securities)
Shares Involved	47,990 (36,564 + 11,426)
Price Per Share	$71.87
Total Value	$3,449,506.70
Ownership Type	Direct

Final shares owned after all transactions: 79,010

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value (Market Value of Grant)	~$5,174,640
% of Market Cap	~0.048%
Shares Transacted (Grant)	72,000
% of Shares Outstanding	Not Available
Post-Transaction Ownership	79,010 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Avidity Biosciences has a market capitalization of $10.67 billion. The grant's market value of ~$5.2 million represents a very small fraction (~0.048%) of the company's total valuation, classifying it as a low-significance event.
• Transaction Significance: The disposals (Code 'F') are explicitly noted as shares withheld to cover tax liabilities associated with the vesting of both Performance Stock Units (PSUs) and Restricted Stock Units (RSUs). These are not open-market sales and do not reflect a change in the insider's sentiment towards the company's future prospects.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transactions are part of a standard executive compensation plan. The sales are non-discretionary and required for tax purposes. Such events are common and typically do not influence investor sentiment.

Volume & Sentiment

• Expected Volume Impact: Minimal. The transactions are largely internal (grant and withholding) and do not represent a large block trade on the open market.
• Sentiment Indicator: Neutral. The filing indicates a routine compensation event, not a discretionary investment decision by the insider.

Additional Context

Transaction Notes

• Special Circumstances: The footnotes clearly state the 72,000 share acquisition is from vested PSUs, and the disposals totaling 47,990 shares were withheld by the issuer to satisfy tax obligations. This is a crucial distinction from a voluntary sale.